Literature DB >> 9123092

Sirolimus: a new agent for clinical renal transplantation.

B D Kahan1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9123092     DOI: 10.1016/s0041-1345(96)00008-5

Source DB:  PubMed          Journal:  Transplant Proc        ISSN: 0041-1345            Impact factor:   1.066


× No keyword cloud information.
  11 in total

Review 1.  Therapeutic drug monitoring of immunosuppressant drugs.

Authors:  A Johnston; D W Holt
Journal:  Br J Clin Pharmacol       Date:  1999-04       Impact factor: 4.335

2.  Immunosuppressive drugs after lung transplantation.

Authors:  N Briffa; R E Morris
Journal:  BMJ       Date:  1998-03-07

3.  Gender-related assessment of cyclosporine/prednisolone/sirolimus interactions in three human lymphocyte proliferation assays.

Authors:  G M Ferron; N A Pyszczynski; W J Jusko
Journal:  Transplantation       Date:  1998-05-15       Impact factor: 4.939

Review 4.  Sirolimus: the evidence for clinical pharmacokinetic monitoring.

Authors:  Sunita Bond Stenton; Nilufar Partovi; Mary H H Ensom
Journal:  Clin Pharmacokinet       Date:  2005       Impact factor: 6.447

5.  Everolimus for the treatment of uveitis refractory to cyclosporine A: a pilot study.

Authors:  Arnd Heiligenhaus; Beatrix Zurek-Imhoff; Martin Roesel; Maren Hennig; Daniela Rammrath; Carsten Heinz
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2012-10-17       Impact factor: 3.117

6.  Budget impact analysis of conversion from cyclosporine to sirolimus as immunosuppressive medication in renal transplantation therapy.

Authors:  Naghmeh Foroutan; Hamid R Rasekh; Jamshid Salamzadeh; Hamid R Jamshidi; Mohsen Nafar
Journal:  Clinicoecon Outcomes Res       Date:  2013-10-18

7.  Exploring Sirolimus Pharmacokinetic Variability Using Data Available from the Routine Clinical Care of Renal Transplant Patients - Population Pharmacokinetic Approach.

Authors:  Bojana Golubović; Katarina Vučićević; Dragana Radivojević; Sandra Vezmar Kovačević; Milica Prostran; Branislava Miljković
Journal:  J Med Biochem       Date:  2019-05-11       Impact factor: 3.402

8.  Metformin rescues rapamycin-induced mitochondrial dysfunction and attenuates rheumatoid arthritis with metabolic syndrome.

Authors:  Eun Kyung Kim; Hong Ki Min; Seon-Yeong Lee; Da-Som Kim; Jun-Geol Ryu; Hyun Sik Na; Kyoung Ah Jung; Jeong Won Choi; Sung-Hwan Park; Mi-La Cho
Journal:  Arthritis Res Ther       Date:  2020-04-10       Impact factor: 5.156

9.  Optimization of adipose tissue-derived mesenchymal stem cells by rapamycin in a murine model of acute graft-versus-host disease.

Authors:  Kyoung-Woon Kim; Su-Jin Moon; Min-Jung Park; Bo-Mi Kim; Eun-Kyung Kim; Sung-Hee Lee; Eun-Jung Lee; Byung-Ha Chung; Chul-Woo Yang; Mi-La Cho
Journal:  Stem Cell Res Ther       Date:  2015-10-23       Impact factor: 6.832

10.  Treatment of Erythroid Precursor Cells from β-Thalassemia Patients with Cinchona Alkaloids: Induction of Fetal Hemoglobin Production.

Authors:  Cristina Zuccato; Lucia Carmela Cosenza; Matteo Zurlo; Ilaria Lampronti; Monica Borgatti; Chiara Scapoli; Roberto Gambari; Alessia Finotti
Journal:  Int J Mol Sci       Date:  2021-12-14       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.